nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—HTR1A—Parkinson's disease	0.575	0.625	CbGaD
Nebivolol—CYP2D6—Parkinson's disease	0.345	0.375	CbGaD
Nebivolol—HTR1A—telencephalic ventricle—Parkinson's disease	0.00178	0.188	CbGeAlD
Nebivolol—HTR1A—hindbrain—Parkinson's disease	0.000839	0.0886	CbGeAlD
Nebivolol—ADRB1—forebrain—Parkinson's disease	0.000541	0.0571	CbGeAlD
Nebivolol—HTR1A—brainstem—Parkinson's disease	0.000481	0.0508	CbGeAlD
Nebivolol—HTR1A—forebrain—Parkinson's disease	0.000464	0.049	CbGeAlD
Nebivolol—ADRB1—cardiovascular system—Parkinson's disease	0.000457	0.0483	CbGeAlD
Nebivolol—CYP2D6—hindbrain—Parkinson's disease	0.000455	0.0481	CbGeAlD
Nebivolol—HTR1A—cardiovascular system—Parkinson's disease	0.000392	0.0414	CbGeAlD
Nebivolol—ADRB1—head—Parkinson's disease	0.00031	0.0327	CbGeAlD
Nebivolol—HTR1A—midbrain—Parkinson's disease	0.000306	0.0323	CbGeAlD
Nebivolol—HTR1A—spinal cord—Parkinson's disease	0.000299	0.0316	CbGeAlD
Nebivolol—ADRB1—nervous system—Parkinson's disease	0.000294	0.031	CbGeAlD
Nebivolol—ADRB1—central nervous system—Parkinson's disease	0.000283	0.0298	CbGeAlD
Nebivolol—HTR1A—head—Parkinson's disease	0.000266	0.028	CbGeAlD
Nebivolol—CYP2D6—brainstem—Parkinson's disease	0.000261	0.0276	CbGeAlD
Nebivolol—CYP2D6—forebrain—Parkinson's disease	0.000252	0.0266	CbGeAlD
Nebivolol—HTR1A—nervous system—Parkinson's disease	0.000252	0.0266	CbGeAlD
Nebivolol—HTR1A—central nervous system—Parkinson's disease	0.000243	0.0256	CbGeAlD
Nebivolol—HTR1A—cerebellum—Parkinson's disease	0.000237	0.025	CbGeAlD
Nebivolol—ADRB1—brain—Parkinson's disease	0.000224	0.0237	CbGeAlD
Nebivolol—HTR1A—brain—Parkinson's disease	0.000193	0.0203	CbGeAlD
Nebivolol—CYP2D6—head—Parkinson's disease	0.000144	0.0152	CbGeAlD
Nebivolol—CYP2D6—nervous system—Parkinson's disease	0.000137	0.0144	CbGeAlD
Nebivolol—CYP2D6—central nervous system—Parkinson's disease	0.000132	0.0139	CbGeAlD
Nebivolol—CYP2D6—cerebellum—Parkinson's disease	0.000129	0.0136	CbGeAlD
Nebivolol—CYP2D6—brain—Parkinson's disease	0.000105	0.011	CbGeAlD
Nebivolol—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.000101	0.00141	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	0.0001	0.0014	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	9.97e-05	0.00139	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD1—Parkinson's disease	9.91e-05	0.00138	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—GRK5—Parkinson's disease	9.87e-05	0.00138	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	9.84e-05	0.00137	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	9.81e-05	0.00137	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—GRM4—Parkinson's disease	9.75e-05	0.00136	CbGpPWpGaD
Nebivolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	9.74e-05	0.00136	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	9.71e-05	0.00135	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.7e-05	0.00135	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	9.66e-05	0.00135	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD3—Parkinson's disease	9.59e-05	0.00134	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	9.54e-05	0.00133	CbGpPWpGaD
Nebivolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	9.53e-05	0.00133	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	9.49e-05	0.00132	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	9.45e-05	0.00132	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	9.33e-05	0.0013	CbGpPWpGaD
Nebivolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	9.32e-05	0.0013	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—VPS35—Parkinson's disease	9.28e-05	0.00129	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	9.25e-05	0.00129	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PENK—Parkinson's disease	9.24e-05	0.00129	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	9.12e-05	0.00127	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	9.07e-05	0.00127	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	9.07e-05	0.00127	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	9.05e-05	0.00126	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	8.87e-05	0.00124	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	8.87e-05	0.00124	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—GRM4—Parkinson's disease	8.85e-05	0.00123	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	8.84e-05	0.00123	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	8.77e-05	0.00122	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—HTR7—Parkinson's disease	8.68e-05	0.00121	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—DRD2—Parkinson's disease	8.68e-05	0.00121	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	8.64e-05	0.00121	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	8.58e-05	0.0012	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PDYN—Parkinson's disease	8.45e-05	0.00118	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PENK—Parkinson's disease	8.39e-05	0.00117	CbGpPWpGaD
Nebivolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.34e-05	0.00116	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	8.26e-05	0.00115	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	8.24e-05	0.00115	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	8.21e-05	0.00115	CbGpPWpGaD
Nebivolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.16e-05	0.00114	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	8.15e-05	0.00114	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	8.11e-05	0.00113	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	8.09e-05	0.00113	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	8.04e-05	0.00112	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	8.04e-05	0.00112	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	8.04e-05	0.00112	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	8.04e-05	0.00112	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	8.02e-05	0.00112	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	8e-05	0.00112	CbGpPWpGaD
Nebivolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	7.98e-05	0.00111	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	7.87e-05	0.0011	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	7.87e-05	0.0011	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—GRM5—Parkinson's disease	7.86e-05	0.0011	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	7.85e-05	0.00109	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DGKQ—Parkinson's disease	7.69e-05	0.00107	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GPR37—Parkinson's disease	7.69e-05	0.00107	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PDYN—Parkinson's disease	7.68e-05	0.00107	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	7.46e-05	0.00104	CbGpPWpGaD
Nebivolol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.46e-05	0.00104	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	7.36e-05	0.00103	CbGpPWpGaD
Nebivolol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.35e-05	0.00103	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	7.3e-05	0.00102	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	7.26e-05	0.00101	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	7.2e-05	0.001	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—GRM5—Parkinson's disease	7.14e-05	0.000995	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	7.1e-05	0.000991	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PPP1R1B—Parkinson's disease	7.04e-05	0.000981	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.98e-05	0.000974	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—EDN1—Parkinson's disease	6.95e-05	0.000969	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.83e-05	0.000953	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.68e-05	0.000932	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	6.43e-05	0.000897	CbGpPWpGaD
Nebivolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	6.35e-05	0.000886	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	6.34e-05	0.000885	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	6.29e-05	0.000877	CbGpPWpGaD
Nebivolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	6.22e-05	0.000867	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	6.2e-05	0.000865	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RIT2—Parkinson's disease	6.15e-05	0.000858	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	6.1e-05	0.00085	CbGpPWpGaD
Nebivolol—HTR1A—GPCR ligand binding—HTR2A—Parkinson's disease	6.08e-05	0.000848	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—ADORA2A—Parkinson's disease	6.07e-05	0.000846	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	6.06e-05	0.000845	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	5.99e-05	0.000835	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	5.97e-05	0.000832	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	5.96e-05	0.000831	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	5.93e-05	0.000827	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	5.85e-05	0.000816	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	5.84e-05	0.000814	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GRK5—Parkinson's disease	5.83e-05	0.000813	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	5.73e-05	0.000798	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—TAC1—Parkinson's disease	5.71e-05	0.000796	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	5.67e-05	0.000791	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD1—Parkinson's disease	5.6e-05	0.000781	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	5.55e-05	0.000773	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	5.5e-05	0.000768	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	5.47e-05	0.000762	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD3—Parkinson's disease	5.42e-05	0.000756	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	5.42e-05	0.000756	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	5.38e-05	0.000751	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	5.35e-05	0.000746	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	5.32e-05	0.000741	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	5.3e-05	0.000739	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.29e-05	0.000738	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ND3—Parkinson's disease	5.29e-05	0.000737	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.29e-05	0.000737	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GRM4—Parkinson's disease	5.23e-05	0.000729	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	5.2e-05	0.000725	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—TAC1—Parkinson's disease	5.18e-05	0.000723	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	5.18e-05	0.000723	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	5.18e-05	0.000723	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.18e-05	0.000722	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	5.15e-05	0.000718	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	5.13e-05	0.000715	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	5.13e-05	0.000715	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD1—Parkinson's disease	5.08e-05	0.000709	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	5.07e-05	0.000707	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	5.07e-05	0.000707	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.06e-05	0.000706	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	5.04e-05	0.000702	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	5.01e-05	0.000699	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	5.01e-05	0.000699	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—OMD—Parkinson's disease	4.97e-05	0.000693	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.97e-05	0.000693	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PENK—Parkinson's disease	4.96e-05	0.000691	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAG—Parkinson's disease	4.96e-05	0.000691	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD3—Parkinson's disease	4.92e-05	0.000687	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—DRD2—Parkinson's disease	4.9e-05	0.000684	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—HTR7—Parkinson's disease	4.9e-05	0.000684	CbGpPWpGaD
Nebivolol—HTR1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.83e-05	0.000674	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	4.81e-05	0.00067	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	4.74e-05	0.000661	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.71e-05	0.000657	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	4.7e-05	0.000656	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	4.66e-05	0.000649	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	4.66e-05	0.000649	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	4.64e-05	0.000647	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	4.6e-05	0.000641	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	4.55e-05	0.000635	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	4.55e-05	0.000635	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	4.53e-05	0.000632	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.49e-05	0.000627	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	4.46e-05	0.000622	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	4.45e-05	0.000621	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	4.45e-05	0.000621	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	4.41e-05	0.000615	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	4.36e-05	0.000608	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	4.31e-05	0.000601	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	4.26e-05	0.000594	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	4.22e-05	0.000588	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	4.1e-05	0.000572	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	4.02e-05	0.00056	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GBA—Parkinson's disease	4.01e-05	0.000559	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.01e-05	0.000559	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—DBH—Parkinson's disease	4.01e-05	0.000559	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	3.93e-05	0.000548	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	3.86e-05	0.000539	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	3.78e-05	0.000527	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	3.75e-05	0.000523	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	3.73e-05	0.00052	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	3.7e-05	0.000515	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	3.67e-05	0.000511	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	3.65e-05	0.000508	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.59e-05	0.000501	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	3.58e-05	0.0005	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	3.57e-05	0.000497	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	3.51e-05	0.00049	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	3.46e-05	0.000482	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	3.43e-05	0.000479	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	3.38e-05	0.000472	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—INSR—Parkinson's disease	3.31e-05	0.000461	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	3.27e-05	0.000456	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	3.26e-05	0.000455	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	3.25e-05	0.000453	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	3.2e-05	0.000447	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	3.2e-05	0.000446	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	3.19e-05	0.000445	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	3.18e-05	0.000444	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	3.14e-05	0.000438	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	3.13e-05	0.000437	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FGB—Parkinson's disease	3.13e-05	0.000436	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	3.12e-05	0.000435	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	3.07e-05	0.000428	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	3.06e-05	0.000427	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	3.04e-05	0.000424	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	3e-05	0.000419	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	2.97e-05	0.000415	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—DDC—Parkinson's disease	2.94e-05	0.00041	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	2.91e-05	0.000406	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	2.84e-05	0.000396	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	2.78e-05	0.000387	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.78e-05	0.000387	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	2.75e-05	0.000384	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	2.75e-05	0.000384	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	2.72e-05	0.000379	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	2.69e-05	0.000375	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	2.69e-05	0.000375	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	2.63e-05	0.000367	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	2.63e-05	0.000367	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.5e-05	0.000349	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.48e-05	0.000345	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	2.3e-05	0.000321	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	2.25e-05	0.000314	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	2.23e-05	0.000311	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	2.2e-05	0.000307	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	2.2e-05	0.000307	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	2.18e-05	0.000304	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	2.15e-05	0.0003	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	2.13e-05	0.000297	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	2.11e-05	0.000294	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	2.02e-05	0.000282	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	1.98e-05	0.000276	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NGF—Parkinson's disease	1.94e-05	0.00027	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	1.93e-05	0.000269	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	1.88e-05	0.000263	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	1.84e-05	0.000257	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.81e-05	0.000252	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	1.79e-05	0.00025	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	1.75e-05	0.000244	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOE—Parkinson's disease	1.71e-05	0.000239	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.68e-05	0.000235	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.66e-05	0.000232	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—TH—Parkinson's disease	1.64e-05	0.000229	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.57e-05	0.00022	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	1.53e-05	0.000213	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	1.5e-05	0.000209	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—INS—Parkinson's disease	1.46e-05	0.000204	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—COMT—Parkinson's disease	1.39e-05	0.000194	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.39e-05	0.000194	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.38e-05	0.000193	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.37e-05	0.000191	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.31e-05	0.000183	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.28e-05	0.000178	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.22e-05	0.00017	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.14e-05	0.000159	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.13e-05	0.000158	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.13e-05	0.000157	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.11e-05	0.000155	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.11e-05	0.000154	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	1.09e-05	0.000152	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	1.08e-05	0.000151	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.05e-05	0.000146	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.05e-05	0.000146	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.02e-05	0.000143	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	1e-05	0.00014	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—INS—Parkinson's disease	8.96e-06	0.000125	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	6.68e-06	9.32e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	6.54e-06	9.12e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—Parkinson's disease	6.39e-06	8.92e-05	CbGpPWpGaD
